Proteomics-Driven Biomarkers in Pancreatic Cancer

Pancreatic cancer is a devastating disease that has a grim prognosis, highlighting the need for improved screening, diagnosis, and treatment strategies. Currently, the sole biomarker for pancreatic ductal adenocarcinoma (PDAC) authorized by the U.S. Food and Drug Administration is CA 19-9, which pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramalhete, Luís, Vigia, Emanuel, Araújo, Rúben, Marques, Hugo Pinto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443269/
https://www.ncbi.nlm.nih.gov/pubmed/37606420
http://dx.doi.org/10.3390/proteomes11030024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443269/
https://www.ncbi.nlm.nih.gov/pubmed/37606420
http://dx.doi.org/10.3390/proteomes11030024

Ejemplares similares